光正眼科医院集团股份有限公司 截至本公告披露日，光正眼科医院集团股份有限公司（以下简称"公司"） 及控股子公司对外担保总额超过最近一期经审计（归母）净资产 100%，均为公 司、控股子公司、全资子公司及其下属公司间互相担保。敬请投资者关注担保风 险。 一、概述 公司于 2025 年 4 月 22 日召开第六届董事会第二次会议和第六届监事会第二 次会议，分别审议通过了《关于 2025 年度向银行等相关金融机构申请综合授信 额度并提供担保的议案》，同意根据公司 2025 年度生产经营计划和发展规划， 为保证公司正常经营的资金需求，公司、公司合并报表范围内的下属控股子公司 及孙公司（简称"控股子公司"）2025 年度拟将向银行等相关金融机构申请总 额不超过 6.5 亿元的综合授信（包括但不限于：信用贷款、第三方担保贷款、资 产抵押贷款、银行承兑汇票、银行保函、保理、贸易融资、并购贷款、医保贷款、 融资性租赁等业务），公司将根据实际生产经营的资金需求及在金融机构的授信 情况，综合考虑各银行等相关金融机构信贷规模，融资期限和融资成本等条件， 进行比选择优。公司及其控股公司之间提供的担保总额度可循环使用；授信及担 保额度 ...

光正眼科医院集团股份有限公司 证券代码：002524 证券简称：光正眼科 公告编号：2025-065 光正眼科医院集团股份有限公司 关于下属子公司综合授信及担保事项的进展公告 本公司及董事会全体成员保证信息披露的内容真实、准确、完整，没有虚假 记载、误导性陈述或重大遗漏。 1 / 5 光正眼科医院集团股份有限公司 及巨潮资讯网（http://www.cninfo.com.c）的《关于 2025 年度向银行等相关金 融机构申请综合授信额度并提供担保的议案》（公告编号：2025-033）。2025 年 5 月 20 日，公司召开 2024 年年度股东大会审议通过了上述议案。 二、进展情况 近日，公司全资子公司上海光正新视界眼科医院投资有限公司（以下简称"光 正新视界"）下属子公司山南康佳医疗器械有限公司（以下简称"山南康佳"） 向中国银行股份有限公司山南分行申请人民币 1,000 万元的授信额度，公司为该 笔授信业务的本息还付提供连带责任担保。 特别提示： 截至本公告披露日，光正眼科医院集团股份有限公司（以下简称"公司"） 及控股子公司对外担保总额超过最近一期经审计（归母）净资产 100%，均为公 司、控股子公司 ...

光正眼科医院集团股份有限公司 注：本次质押不涉及负担重大资产重组等业绩补偿义务。 2.本次股份解除质押的情况 证券代码：002524 证券简称：光正眼科 公告编号：2025-064 光正眼科医院集团股份有限公司 关于控股股东部分股份质押及解除质押的公告 本公司及董事会全体成员保证信息披露的内容真实、准确、完整，没有虚假 记载、误导性陈述或重大遗漏。 一、本次股份质押的基本情况 光正眼科医院集团股份有限公司（以下简称"公司"）近日接到控股股东光 正投资有限公司（以下简称"光正投资"）函告，获悉光正投资将所持有本公司 的部分股份办理了质押及解除质押的相关手续，具体情况如下： 1.本次股份质押的基本情况 | | 是否为控 | | | | 是 否 | 是 否 | | | | | | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | | | 股股东或 第一大股 | 本次质押数 | 占其所 持股份 | 占公司 总股本 | 为 | 为 | 质押起始 | 质押到期 | 质权人 | 质押 | | | | | | | 限 | 补 | 日 | 日 | ...

Core Viewpoint - The announcement indicates that the controlling shareholder, Guangzheng Investment, has pledged 64.6 million shares, representing 50.01% of its holdings and 12.46% of the company's total share capital, to Shenzhen Hangjia Source Holdings for operational purposes [1] Summary by Relevant Sections - **Pledge Details** - Guangzheng Investment has pledged 64.6 million shares with a pledge period from September 22, 2025, to September 22, 2027 [1] - On September 23, 34.9199 million shares were released from pledge [1] - **Financial Implications** - The total pledged shares correspond to a financing balance of 130 million yuan within the next two years [1] - Guangzheng Investment's credit and financial status are reported to be good, with no risk of forced liquidation or transfer of pledged shares [1] - **Impact on the Company** - The current pledge is stated to have no impact on the company [1]

| | 是否为控 股股东或 | | 占其所 | 占公司 | 是 否 | 是 否 | | | | | | | | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | | | 第一大股 | 本次质押数 | 持股份 | 总股本 | 为 限 | 为 补 | 质押 | | 质押 | | | 质押 | | 股东名称 | 东及其一 | 量（股） | 比例 | 比例 | 售 | 质 | 起始日 | | 到期日 | | 质权人 | 用途 | | | 致行动人 | | | | 股 | 押 | | | | | | | | 光正 | | 15,399,900 | 11.92 | 2.97% | | | 2025 年 | 9 | 2025 | 年 | 华安证券股 | | | 投资 | 是 | | % | | 否 | 否 | 月 19 | 日 | 10 月 31 | | 份有限公司 | 融资 | | | | | | | | | | | 日 | | | | | 合计 | | 15,399,90011.92% | | 2.97% | | ...

Group 1 - The core point of the article is that Guangzheng Eye Hospital has announced the pledge renewal and release of shares by its controlling shareholder, Guangzheng Investment, which has pledged approximately 34.92 million shares, accounting for 27.03% of its holdings [1] - As of the announcement date, Guangzheng Eye Hospital's market capitalization is 2.1 billion yuan [1] - For the first half of 2025, the revenue composition of Guangzheng Eye Hospital is as follows: 91.5% from the health industry, 5.46% from steel structure engineering, and 3.04% from the energy sector [1]

证券代码：002524 证券简称：光正眼科 公告编号：2025-062 光正眼科医院集团股份有限公司 光正眼科医院集团股份有限公司 关于下属子公司综合授信及担保事项的进展公告 本公司及董事会全体成员保证信息披露的内容真实、准确、完整，没有虚假 记载、误导性陈述或重大遗漏。 特别提示： 截至本公告披露日，光正眼科医院集团股份有限公司（以下简称"公司"） 及控股子公司对外担保总额超过最近一期经审计（归母）净资产 100%，均为公 司、控股子公司、全资子公司及其下属公司间互相担保。敬请投资者关注担保风 险。 一、概述 公司于 2025 年 4 月 22 日召开第六届董事会第二次会议和第六届监事会第二 次会议，分别审议通过了《关于 2025 年度向银行等相关金融机构申请综合授信 额度并提供担保的议案》，同意根据公司 2025 年度生产经营计划和发展规划， 为保证公司正常经营的资金需求，公司、公司合并报表范围内的下属控股子公司 及孙公司（简称"控股子公司"）2025 年度拟将向银行等相关金融机构申请总 额不超过 6.5 亿元的综合授信（包括但不限于：信用贷款、第三方担保贷款、资 产抵押贷款、银行承兑汇票、银行保函、保理 ...

Core Viewpoint - Guangzheng Eye Hospital announced progress on comprehensive credit and guarantee matters for its subsidiaries, indicating a strategic move to secure financial support for operations and growth [1] Group 1: Credit and Guarantee Details - In April 2025, a meeting approved the proposal for the company and its controlling subsidiaries to apply for a comprehensive credit limit not exceeding 650 million yuan from financial institutions [1] - The shareholders' meeting in May approved the proposal to provide mutual guarantees totaling no more than 650 million yuan [1] - Recently, its wholly-owned subsidiaries, Zhongxing Eye Hospital and New Vision Eye Hospital, applied for a credit limit of 30 million yuan from the Shanghai branch of China Merchants Bank, with the company and related parties providing joint liability guarantees [1] Group 2: Financial Impact - Following this guarantee, the total guarantee amount for the company and its subsidiaries reached 51.109 million yuan, which accounts for 453.50% of the latest audited net assets attributable to the parent company [1] - All guarantees are internal mutual guarantees, with no external guarantee risks involved [1]

Core Points - The company, Guangzheng Eye Hospital, announced the convening of its second extraordinary general meeting of shareholders for 2025 on September 4, 2025 [1] - The meeting approved the proposal regarding the repurchase and cancellation of certain restricted stocks granted under the 2023 restricted stock incentive plan that have not yet been released from restrictions [1]

Core Viewpoint - The legal opinion issued by Xinjiang Tianyang Law Firm confirms that the procedures for the convening and holding of the 2025 Second Extraordinary General Meeting of Shareholders of Guangzheng Eye Hospital Group Co., Ltd. comply with relevant laws and regulations, ensuring the legality and validity of the meeting [1][5][6] Group 1: Meeting Procedures - The board of directors announced the notice for the 2025 Second Extraordinary General Meeting on July 17, 2025, and a supplementary notice on August 22, 2025, detailing the meeting's agenda, date, and voting procedures [3][4] - The meeting was convened by the sixth board of directors and conducted through a combination of on-site and online voting, held at the designated company meeting room [4][5] Group 2: Attendance Qualifications - A total of 232 shareholders and their proxies attended the meeting, representing 135,062,596 shares, which accounts for 26.0504% of the company's total share capital [5] - The controlling shareholder, Guangzheng Investment Co., Ltd., holds 24.9136% of the shares and proposed a temporary agenda item for the meeting [4][5] Group 3: Voting Procedures - The meeting voted on three agenda items using both on-site and online voting methods, with all items passing by a majority of over two-thirds of the valid votes cast [5][6] - The results of the voting were announced immediately following the completion of the voting process [5] Group 4: Conclusion - The legal opinion concludes that all aspects of the meeting, including the convening procedures, qualifications of attendees, voting methods, and results, are in compliance with the Company Law, Securities Law, and the company's articles of association, thus affirming the meeting's legality [5][6]